INS and Alzheimer disease: The level of mTORC1 activation following insulin stimulation was not different from healthy controls at any treatment day for AD subjects, although the Day 28 insulin-stimulated mTORC1 activation level was significantly higher than at Day 0 for AD subjects (p < 0.001).